Life Care Center Of Crossville | |
80 Justice St, Crossville, Tennessee 38555 | |
(931) 484-4782 | |
Name | Life Care Center Of Crossville |
---|---|
Location | 80 Justice St, Crossville, Tennessee |
Certified By | Medicare and Medicaid |
No. of Certified Beds | 122 |
Occupancy Rate | 54.59% |
Medicare ID (CCN) | 445167 |
Legal Business Name | Crossville Medical Investors, Llc |
Ownership Type | For Profit - Corporation |
NPI Number | 1073523692 |
Organization Name | COUNTRY PLACE HEALTH CARE CENTER |
Address | 80 Justice Street, Crossville, TN 38555 |
Phone Number | 931-484-4782 |
News Archive
The Clalit Research Institute, in collaboration with researchers from Harvard University, analyzed one of the world's largest integrated health record databases to examine the safety of the Pfizer/BioNTech BNT162B2 vaccine against COVID-19.
Advanced Cell Technology, Inc., a leader in the field of regenerative medicine, announced today first quarter financial results for the period ended March 31, 2011. The Company reported a loss from operations of $(4.8) million compared to a loss from operations of $(15.0) million in the 2010 first quarter.
In February, a month after Haiti's earthquake, I went down to Port-au-Prince as part of a team that was helping to reactivate cardiac care in the city's public hospital. For several months since, I have observed how the earthquake and its aftermath profoundly changed Haiti's health care system. Over that time, I have come to the unorthodox conclusion that Haiti's tragic experience may show us a way to improve health care in the United States (James Wilentz, 7/28).
Kaiser Permanente today donated its Convergent Medical Terminology (CMT) to the International Healthcare Terminology Standards Development Organisation (IHTSDO) for U.S. distribution through the U.S. Department of Health and Human Services (HHS) so that all health care providers arge and small can benefit from the translation-enabling technology.
Medtronic, Inc., announced today that the U.S. Food and Drug Administration (FDA) has conditionally approved the protocol for SYMPLICITY HTN-3, the company's U.S. clinical trial of renal denervation with the Symplicity Catheter System for the treatment of resistant hypertension, an especially dangerous disease affecting hundreds of millions of people worldwide.
› Verified 5 days ago
NPI Number | 1154572618 |
Organization Name | CROSSVILLE MEDICAL INVESTORS, LLC |
Doing Business As | LIFE CARE CENTER OF CROSSVILLE |
Address | 80 Justice St, Crossville, TN 38555 |
Phone Number | 423-473-5751 |
News Archive
The Clalit Research Institute, in collaboration with researchers from Harvard University, analyzed one of the world's largest integrated health record databases to examine the safety of the Pfizer/BioNTech BNT162B2 vaccine against COVID-19.
Advanced Cell Technology, Inc., a leader in the field of regenerative medicine, announced today first quarter financial results for the period ended March 31, 2011. The Company reported a loss from operations of $(4.8) million compared to a loss from operations of $(15.0) million in the 2010 first quarter.
In February, a month after Haiti's earthquake, I went down to Port-au-Prince as part of a team that was helping to reactivate cardiac care in the city's public hospital. For several months since, I have observed how the earthquake and its aftermath profoundly changed Haiti's health care system. Over that time, I have come to the unorthodox conclusion that Haiti's tragic experience may show us a way to improve health care in the United States (James Wilentz, 7/28).
Kaiser Permanente today donated its Convergent Medical Terminology (CMT) to the International Healthcare Terminology Standards Development Organisation (IHTSDO) for U.S. distribution through the U.S. Department of Health and Human Services (HHS) so that all health care providers arge and small can benefit from the translation-enabling technology.
Medtronic, Inc., announced today that the U.S. Food and Drug Administration (FDA) has conditionally approved the protocol for SYMPLICITY HTN-3, the company's U.S. clinical trial of renal denervation with the Symplicity Catheter System for the treatment of resistant hypertension, an especially dangerous disease affecting hundreds of millions of people worldwide.
› Verified 5 days ago
Ratings from Surveys (Inspections): | |
Ratings from Quality Measures: | |
Ratings from Staffing Data: | |
Overall Rating: |
---|
News Archive
The Clalit Research Institute, in collaboration with researchers from Harvard University, analyzed one of the world's largest integrated health record databases to examine the safety of the Pfizer/BioNTech BNT162B2 vaccine against COVID-19.
Advanced Cell Technology, Inc., a leader in the field of regenerative medicine, announced today first quarter financial results for the period ended March 31, 2011. The Company reported a loss from operations of $(4.8) million compared to a loss from operations of $(15.0) million in the 2010 first quarter.
In February, a month after Haiti's earthquake, I went down to Port-au-Prince as part of a team that was helping to reactivate cardiac care in the city's public hospital. For several months since, I have observed how the earthquake and its aftermath profoundly changed Haiti's health care system. Over that time, I have come to the unorthodox conclusion that Haiti's tragic experience may show us a way to improve health care in the United States (James Wilentz, 7/28).
Kaiser Permanente today donated its Convergent Medical Terminology (CMT) to the International Healthcare Terminology Standards Development Organisation (IHTSDO) for U.S. distribution through the U.S. Department of Health and Human Services (HHS) so that all health care providers arge and small can benefit from the translation-enabling technology.
Medtronic, Inc., announced today that the U.S. Food and Drug Administration (FDA) has conditionally approved the protocol for SYMPLICITY HTN-3, the company's U.S. clinical trial of renal denervation with the Symplicity Catheter System for the treatment of resistant hypertension, an especially dangerous disease affecting hundreds of millions of people worldwide.
› Verified 5 days ago
Number of Facility Reported Incidents | 0 |
Number of Substantiated Complaints | 0 |
Number of Fines | 0 |
Total Amount of Fines in Dollars | $0 |
Number of Payment Denials | 0 |
Total Number of Penalties | 0 |
Experience Measure | Provider | National Avg. |
---|---|---|
Percentage of long-stay residents whose need for help with daily activities has increased | 22.88 | 14.46 |
Percentage of long-stay residents who lose too much weight | 12.83 | 5.51 |
Percentage of low risk long-stay residents who lose control of their bowels or bladder | 49.28 | 48.41 |
Percentage of long-stay residents with a catheter inserted and left in their bladder | 1.84 | 1.79 |
Percentage of long-stay residents with a urinary tract infection | 0 | 2.65 |
Percentage of long-stay residents who have depressive symptoms | 0 | 5.05 |
Percentage of long-stay residents who were physically restrained | 0 | 0.23 |
Percentage of long-stay residents experiencing one or more falls with major injury | 1.41 | 3.36 |
Percentage of long-stay residents assessed and appropriately given the pneumococcal vaccine | 100 | 93.87 |
Percentage of long-stay residents who received an antipsychotic medication | 20.78 | 14.2 |
Percentage of short-stay residents assessed and appropriately given the pneumococcal vaccine | 97.75 | 83.88 |
Percentage of short-stay residents who newly received an antipsychotic medication | 2.3 | 1.79 |
Percentage of long-stay residents whose ability to move independently worsened | 30.27 | 17.09 |
Percentage of long-stay residents who received an antianxiety or hypnotic medication | 38.65 | 19.7 |
Percentage of high risk long-stay residents with pressure ulcers | 6.64 | 7.32 |
Percentage of long-stay residents assessed and appropriately given the seasonal influenza vaccine | 99.05 | 95.98 |
Percentage of short-stay residents who made improvements in function | 67.57 | 67.99 |
Percentage of short-stay residents who were assessed and appropriately given the seasonal influenza vaccine | 93.42 | 82.93 |
News Archive
The Clalit Research Institute, in collaboration with researchers from Harvard University, analyzed one of the world's largest integrated health record databases to examine the safety of the Pfizer/BioNTech BNT162B2 vaccine against COVID-19.
Advanced Cell Technology, Inc., a leader in the field of regenerative medicine, announced today first quarter financial results for the period ended March 31, 2011. The Company reported a loss from operations of $(4.8) million compared to a loss from operations of $(15.0) million in the 2010 first quarter.
In February, a month after Haiti's earthquake, I went down to Port-au-Prince as part of a team that was helping to reactivate cardiac care in the city's public hospital. For several months since, I have observed how the earthquake and its aftermath profoundly changed Haiti's health care system. Over that time, I have come to the unorthodox conclusion that Haiti's tragic experience may show us a way to improve health care in the United States (James Wilentz, 7/28).
Kaiser Permanente today donated its Convergent Medical Terminology (CMT) to the International Healthcare Terminology Standards Development Organisation (IHTSDO) for U.S. distribution through the U.S. Department of Health and Human Services (HHS) so that all health care providers arge and small can benefit from the translation-enabling technology.
Medtronic, Inc., announced today that the U.S. Food and Drug Administration (FDA) has conditionally approved the protocol for SYMPLICITY HTN-3, the company's U.S. clinical trial of renal denervation with the Symplicity Catheter System for the treatment of resistant hypertension, an especially dangerous disease affecting hundreds of millions of people worldwide.
› Verified 5 days ago
Life Care Center Of Crossville Location: 80 Justice St, Crossville, Tennessee 38555 Phone: (931) 484-4782 | |
Wyndridge Health And Rehab Ctr Location: 456 Wayne Avenue, Crossville, Tennessee 38555 Phone: (931) 484-6129 | |
Good Samaritan Society - Fairfield Glade Location: 100 Samaritan Way, Crossville, Tennessee 38558 Phone: (931) 456-1576 |